Serum levels of Th1/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome

Laboratory Hematology

Volumn 12, Issue 2, 2006, Pages 71-74

  Murohashi, Ikuo ^a   Yoshida, Katsuhiko ^b   Ihara, Noriko ^a   Wakao, Daisuke ^b   Yagasaki, Fumiharu ^b   Nakamura, Yuichi ^b   Kawai, Nobutaka ^b   Matsuda, Akira ^b   Jinnai, Itsuro ^b   Bessho, Masami ^b  

^a SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

IFN ; IL 10; IL 18; Virus associated hemophagocytic syndrome; Young adult

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; FERRITIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE SULFATE; ANGIOGENIC PROTEIN; GROWTH PROMOTOR;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FATALITY; FEMALE; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HUMAN; IMMUNE RESPONSE; LIVER DYSFUNCTION; LYMPHADENOPATHY; MALE; PANCYTOPENIA; PLASMAPHERESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; SPLENOMEGALY; TH1 CELL; TH2 CELL; VIRUS INFECTION; BLOOD; CELLULAR IMMUNITY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; IMMUNOLOGY;

ADULT; ANGIOGENIC PROTEINS; CYTOKINES; FEMALE; GROWTH SUBSTANCES; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-18; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; PROGNOSIS; TH1 CELLS; TH2 CELLS;

EID: 33745883752     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.05035     Document Type: Article

References (19)

1. Risdall RJ, Mckenna RW, Nesbit ME, et al. Virus associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979;44:993-1002.
2. Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100-4103.
3. Takada H, Ohga S, Mizuno Y, et al. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol. 1999;106:182-189.
4. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol. 1997;66:135-151.
5. Ishii E, Ohga S, Imashuku S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol. 2005;53:209-223.
6. Sirono K, Tsuda H. Virus-associated haemophagocytic syndrome in previously healthy adults. Eur J Haematol. 1995;55:240-244.
7. Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994;87:243-250.
8. Kodama K, Kuno H, Koide M, et al. Virus-associated haemophagocytic syndrome responsive to steroid pulse therapy and double filtration plasmapheresis. Clin Lab Haematol. 2000;22:179-181.
9. Amenomori M, Migita K, Miyashita T, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol. 2005;23:100-102.
10. Tsuda H. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol. 1997;65:215-226.
11. Wakao D, Murohashi I, Tominaga K, et al. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma. Ann Hematol. 2002;81:140-146.
12. Imashuku S, Hibi S, Fujisawa F, et al. Haemophagocytic lymphohistiocytosis, interferon-gammanaemia and Epstein-Barr virus involvement. Br J Haematol. 1994;88:656-658.
13. + human blood mononuclear cells. J Clin Invest. 1998; 101:711-721.
14. Kohka H, Yoshino T, Iwagaki H, et al. Interleukin-18/ interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukocyte Biol. 1998;4:519-527.
15. Dai SM, Matsuno H, Nakamura H, et al. Interleukin-18 enhances monocyte tumor necrisis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 2004;50:432-443.
16. Jorgensen C, Apparailly F, Sany J. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? Ann Rheum Dis. 1999;58:136-141.
17. D'Andrea A, Aste-Amezaga M, Valiante NM, et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimultory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993;178:1041-1048.
18. Zediak VP, Hunter CA. IL-10 fails to inhibit the production of IL-18 in response to inflammatory stimuli. Cytokine. 2003;21:84-90.
19. Carmet P. Angiogenesis in health and disease. Nat Med. 2003;9:653-660.